Evidence map›Paper›PMID 25548225›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Modulating DNA methylation in activated CD8+ T cells inhibits regulatory T cell-induced binding of Foxp3 to the CD8+ T Cell IL-2 promoter.

Michelle M Miller, Nnenna Akaronu, Elizabeth M Thompson, Sylvia F Hood, Jonathan E Fogle

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michelle M MillerDepartment of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607.
Nnenna AkaronuDepartment of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607.
Elizabeth M ThompsonDepartment of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607.
Sylvia F HoodDepartment of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607.
Jonathan E FogleDepartment of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27607 jefogle@ncsu.edu.
North Carolina State University · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
Initiative for Maximizing Student Diversity in Biomedical and Behavioral SciencesR25GM083242 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI MACKAY, TRUDY F. · 2008 to 2016
$5.2M
AIDS Lentivirus-induced TGF-beta+ Treg cells Mediate T cell Immune DysfunctionR01AI080288 · NIAID · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI TOMPKINS, MARY B · 2009 to 2012
$1.5M
T regulatory cell suppression of CD8+ cell responses during FIV InfectionK08AI074445 · NIAID · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI FOGLE, JONATHAN · 2008 to 2012
$582k
NIAID NIH HHS AI027757NIAID NIH HHS AI080288NIAID NIH HHS K08 AI074445NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI027767-24NIAID NIH HHS R01 AI080288NIGMS NIH HHS 5R25GM083242NIGMS NIH HHS R25 GM083242
6 · The paper itself

Abstract

We have previously demonstrated that CD4(+)CD25(+) regulatory T cells (Tregs) activated during the course of feline immunodeficiency virus (FIV) infection suppress CD8(+) CTL function in a TGF-β-dependent fashion, inhibiting IFN-γ and IL-2 production and inducing G1 cell-cycle arrest. In this article, we describe the molecular events occurring at the IL-2 promoter leading to suppression of IL-2 production. These experiments demonstrate that Foxp3 induced by lentivirus-activated Tregs in the CD8(+) target cells binds to the IL-2 promoter, actively repressing IL-2 transcription. We further demonstrate that the chronic activation of CD8(+) T cells during FIV infection results in chromatin remodeling at the IL-2 promoter, specifically, demethylation of CpG residues. These DNA modifications occur during active transcription and translation of IL-2; however, these changes render the IL-2 promoter permissive to Foxp3-induced transcriptional repression. These data help explain, in part, the seemingly paradoxical observations that CD8(+) T cells displaying an activation phenotype exhibit altered antiviral function. Further, we demonstrate that blocking demethylation of CpG residues at the IL-2 promoter inhibits Foxp3 binding, suggesting a potential mechanism for rescue and/or reactivation of CD8(+) T cells. Using the FIV model for lentiviral persistence, these studies provide a framework for understanding how immune activation combined with Treg-mediated suppression may affect CD8(+) T cell IL-2 transcription, maturation, and antiviral function.

Indexed as

DNA MethylationPromoter Regions, GeneticAnimalsBase SequenceCatsCD8-Positive T-LymphocytesChromatin Assembly and DisassemblyCoculture TechniquesForkhead Transcription FactorsGene Expression RegulationImmunodeficiency Virus, FelineInterleukin-2LentivirusLymphocyte ActivationModels, BiologicalMolecular Sequence DataForkhead Transcription FactorsInterleukin-2

Identifiers

PMID25548225
PMCPMC4297683
OpenAlexW1613451631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.